Arbidol API Raw Material GMP Pharmaceutical Grade

• Function: Antibiotic and Antimicrobial Agents
• Certification: GMP
• Grade Standard: Medicine Grade
• Type: Chemical Reagent
• State: Solid
• Volatile: Not Volatile
• Model NO.: CAS: 131707-23-8
• Manufacturer: Yes
• Transport Package: Carton or Drum
• Trademark: SHIMEN
• Origin: Hebei China
• Production Capacity: 500000

Product Description

Arbidol

Moleculer weight: C₂₂H₂₆BrClN₂O₃S
CAS: 131707-23-8
Indication:

The main ingredient of Arbidol hydrochloride is arbidol hydrochloride, which is suitable for the treatment of upper respiratory tract infection caused by influenza A and B viruses.  

This product is used for prevention and treatment of epidemic cold, by inhibiting the fusion of influenza virus lipid membrane and host cells and blocking virus replication.  The results showed that the product could directly inhibit the replication of influenza A and B virus by cell culture in vitro and reduce the mortality of mice infected with influenza virus by animal test in vivo.  This product has interferon induction.  

 

SSY Group Limited, established in 1948, principally specializes in R&D, manufacture, and sale of a widerange of pharmaceutical products, including various dosage forms such as intravenous injections, tablets, capsule, ampoules, APIs and medical packaging materials.The main subsidiaries of SSY are as follows
Shijiazhuang No 4 Pharmaceutical Co, Ltd
Hebei Guangxiang Pharmaceutical Co, Ltd.
Hebei Guolong Pharmaceutical Co, Ltd
Jiangsu Best New Medical Material Co, Ltd.
Hebei Hanlin Bio-tech Co., Ltd.
With more than 70-year development, our products
have been sold to both domestic and overseas markets up to more than 80 countries and regions. 
 

Hebei Guangxiang Pharmaceutical Co., Ltd. is a super-large pharmaceutical enterprise, with 3 billion RMB investment and an area of 1000mu(equals to about 667,000m²) in the Biomedical Industrial Park of Cangzhou Bohai New Area. It seizes the timely opportunity of Beijing-Tianjin-Hebei integrated development and firmly relies on the abundant capital, R&D strength and brand influence of SSY Group. Concentrating on API, intermediate compounds and bio-pharmaceutical preparations, its main products are API series products, metronidazole, nifedipine, theophylline, aminophylline, azithromycin, abidol and other series of products and biomedical preparations.
The manufacturing of main products among them- API series products replaces traditional intermittent production into intelligent continuous production with advanced process equipment, automation and information technology, greatly improving production efficiency.